Clinical landscape of oncolytic virus research in 2020 by Howard L Kaufman, Rizwan Haq, Nicholas Macedo, David M Miller

Get full text

Clindamycin 1% Nano-emulsion Gel Formulation for the Treatment of Acne Vulgaris: Results of a Randomized, Active Controlled, Multicentre, Phase IV Clinical Trial by Bhavik Bhavsar, Bimal Choksi, Jayesh Sanmukhani, Alka Dogra, Rizwan Haq, Sudhanshu Mehta, Santanu Mukherjee, V Subramanian, Shafiq Sheikh, Ravindra Mittal

Get full text

Complex inter-relationship of body mass index, gender and serum creatinine on survival: exploring the obesity paradox in melanoma patients treated with checkpoint inhibition by Girish S. Naik, Sushrut S. Waikar, Alistair E. W. Johnson, Elizabeth I. Buchbinder, Rizwan Haq, F. Stephen Hodi, Jonathan D. Schoenfeld, Patrick A. Ott

Get full text

YY1 regulates melanocyte development and function by cooperating with MITF. by Juying Li, Jun S Song, Robert J A Bell, Thanh-Nga T Tran, Rizwan Haq, Huifei Liu, Kevin T Love, Robert Langer, Daniel G Anderson, Lionel Larue, David E Fisher

Get full text

317 B7-H3-targeted CAR T cell with an inducible caspase 9 suicide gene effectively eradicates uveal melanoma liver metastases by Yi Sun, Cristina R Ferrone, Rizwan Haq, Soldano Ferrone, Genevieve M Boland, Sandra Ryeom, Russell W Jenkins, Giulia Cattaneo, Marco Ventin, Shahrzad Arya, Jingyu Jia, Luke Maggs, Xinhui Wang, Bruce R Ksander

Combining CTLA-4 and angiopoietin-2 blockade in patients with advanced melanoma: a phase I trial by Mariano Severgnini, Rizwan Haq, Anita Giobbie-Hurder, Scott J Rodig, Patrick A Ott, Evisa Gjini, Ryan J Sullivan, Donald P Lawrence, Matthew Nazzaro, Kathleen L Pfaff, Jacquelyn O Wolff, Elizabeth I Buchbinder

Get full text

Nivolumab maintenance improves overall survival of patients with advanced melanoma who experience severe immune-related adverse events on nivolumab plus ipilimumab by David Liu, F Stephen Hodi, Rizwan Haq, Anita Giobbie-Hurder, Ann W Silk, Patrick A Ott, Tamara A Sussman, Elizabeth I Buchbinder, Anna K Maloney, Nikita Katukota, Miklos C Fogarasi, Megan Insco

Get full text

Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockade by Elizabeth I. Buchbinder, Jason L. Weirather, Michael Manos, Brian J. Quattrochi, Lynette M. Sholl, Ryan C. Brennick, Peter Bowling, Nancy Bailey, Lisa Magarace, Patrick A. Ott, Rizwan Haq, Benjamin Izar, Anita Giobbie‐Hurder, F. Stephen Hodi

Get full text

Destabilization of NOXA mRNA as a common resistance mechanism to targeted therapies by Joan Montero, Cécile Gstalder, Daniel J. Kim, Dorota Sadowicz, Wayne Miles, Michael Manos, Justin R. Cidado, J. Paul Secrist, Adriana E. Tron, Keith Flaherty, F. Stephen Hodi, Charles H. Yoon, Anthony Letai, David E. Fisher, Rizwan Haq

Get full text

Clinical profiling of BCL-2 family members in the setting of BRAF inhibition offers a rationale for targeting de novo resistance using BH3 mimetics. by Dennie T Frederick, Roberto A Salas Fragomeni, Aislyn Schalck, Isabel Ferreiro-Neira, Taylor Hoff, Zachary A Cooper, Rizwan Haq, David J Panka, Lawrence N Kwong, Michael A Davies, James C Cusack, Keith T Flaherty, David E Fisher, James W Mier, Jennifer A Wargo, Ryan J Sullivan

Get full text

Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastases by Alexander Z. Wei, Matan Uriel, Agata Porcu, Michael P. Manos, Ann C. Mercurio, Michael M. Caplan, Liam Hulse, Rino S. Seedor, Marta Holovatska, Jasmine Francis, Shaheer A. Khan, Diana E. McDonnell, Dmitry Bogomolny, Takami Sato, Brian P. Marr, Rizwan Haq, Marlana Orloff, Alexander Shoushtari, Richard D. Carvajal

Get full text